SeenewsSeenews
Search
Seenews
AlertsSeenewsSeenews
Searchclose
TOPICS
arrow
COUNTRIES
arrow
INDUSTRY
arrow
Economy
arrow
Browse Economy
Mix and match your focus countries with our advanced search
Investments
arrow
Browse Investments
Mix and match your focus countries with our advanced search
Deals
arrow
Browse Deals
Mix and match your focus countries with our advanced search
Tech
arrow
Browse Tech
Mix and match your focus countries with our advanced search
Green
arrow
Browse Green
Mix and match your focus countries with our advanced search
0/5
You have 5 free articles left this month
You have 0/5 free articles
Sign up to get 5 more free articles this month
SIGN UP
arrow
LOGIN
arrow

Slovenia's Salus cons net profit declines in 2023

Mar 11, 2024, 4:08:54 PMArticle by Radomir Ralev
share
March 11 (SeeNews) - Slovenian pharmaceutical products wholesaler Salus [LJE:SALR] has recorded a consolidated net profit of 10.4 million euro ($11.4 million) in 2023, down from 13.1 million euro in the previous year, it said on Monday.

Slovenia's Salus cons net profit declines in 2023
Author: Salus. License: All rights reserved.

Consolidated net sales revenue went up by an annual 20.9% to 599.4 million euro in 2023, Salus said in a filing with the Ljubljana Stock Exchange.

The group's operating profit decreased to 13.2 million euro from 16 million euro in 2022, while EBITDA totalled 18.9 million euro, down from 20.5 million euro.

Ljubljana-based Salus is one of Slovenia's leading wholesalers of pharmaceutical and medical products.

($ = 0.91413 euro)

Your complete guide to the emerging economies of Southeast Europe. From latest news to bespoke research – the big picture at the tip of your fingers.